Skip to Content

298 Cipla (Duloxetine Hydrochloride Delayed-Release 30 mg)

Pill with imprint 298 Cipla is Clear / White, Capsule-shape and has been identified as Duloxetine Hydrochloride Delayed-Release 30 mg. It is supplied by Cipla USA Inc..

Duloxetine is used in the treatment of back pain; chronic pain; anxiety; depression; diabetic peripheral neuropathy and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Duloxetine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 298 Cipla

Duloxetine hydrochloride delayed-release 30 mg 298 Cipla

Duloxetine Hydrochloride Delayed-Release

Imprint
298 Cipla
Strength
30 mg
Color
Clear / White
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0298
Inactive Ingredients
alcohol, ammonia, butyl alcohol, ferrosoferric oxide, gelatin, hypromellose 2910 (6 mPa.s), hypromellose phthalate (31% phthalate, 40 cst), isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, sucrose, corn starch, magnesium silicate, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.